Product containing precisely insulin aspart (as insulin aspart protamine) 70 unit/1 milliliter and insulin aspart 30 unit/1 milliliter conventional release suspension for injection 3 milliliter cartridge (clinical drug)
| Code | 3468811000001107 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
816007008Insulin aspart biphasic
medicinal product
10363801000001108Virtual medicinal product
product
20163311000001106NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (DE Pharmaceuticals)
real clinical drug
13180611000001108NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Dowelhurst Ltd)
real clinical drug
37695011000001103NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Ethigen Ltd)
real clinical drug
16523811000001107NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Mawdsley-Brooks & Company Ltd)
real clinical drug
17601611000001107NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Necessity Supplies Ltd)
real clinical drug
3277811000001103NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Novo Nordisk Ltd)
real clinical drug
14386011000001106NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Sigma Pharmaceuticals Plc)
real clinical drug
10542911000001101NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Waymade Healthcare Plc)
real clinical drug